Do boys have the same intentions to get the HPV vaccine as girls? Knowledge, attitudes, and intentions in France.

Boys Human papillomavirus Motivational stages Vaccine intention Vaccines

Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
14 Mar 2024
Historique:
received: 05 07 2023
revised: 23 02 2024
accepted: 26 02 2024
medline: 16 3 2024
pubmed: 16 3 2024
entrez: 15 3 2024
Statut: aheadofprint

Résumé

The vaccine coverage against human papillomavirus (HPV) vaccination remains low in France. The objective of this study was to study adolescent perceptions by comparing boys and girls, in order to build effective school-based interventions. This paper presents a cross-sectional study in French middle school pupils. They completed online questionnaires on their knowledge and attitudes toward the HPV vaccine, HPV vaccination status, their intention, reasons to vaccinate or not to vaccinate, and psychological antecedents of vaccination. A structural equation modeling (SEM) analysis was used to test the hypothesized model. The participants are 818 pupils aged from 12 to 16 years (M These findings reveal a high percentage of boys who do not feel concerned by the HPV vaccine and highlight the need to consider the psychological antecedents of vaccination in general in addition to the specific attitudes to the HPV vaccine.

Sections du résumé

BACKGROUND BACKGROUND
The vaccine coverage against human papillomavirus (HPV) vaccination remains low in France. The objective of this study was to study adolescent perceptions by comparing boys and girls, in order to build effective school-based interventions.
METHODS METHODS
This paper presents a cross-sectional study in French middle school pupils. They completed online questionnaires on their knowledge and attitudes toward the HPV vaccine, HPV vaccination status, their intention, reasons to vaccinate or not to vaccinate, and psychological antecedents of vaccination. A structural equation modeling (SEM) analysis was used to test the hypothesized model.
RESULTS RESULTS
The participants are 818 pupils aged from 12 to 16 years (M
CONCLUSIONS CONCLUSIONS
These findings reveal a high percentage of boys who do not feel concerned by the HPV vaccine and highlight the need to consider the psychological antecedents of vaccination in general in addition to the specific attitudes to the HPV vaccine.

Identifiants

pubmed: 38490822
pii: S0264-410X(24)00256-1
doi: 10.1016/j.vaccine.2024.02.080
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Catherine Juneau (C)

Laboratoire Inter-universitaire de Psychologie, Université Grenoble Alpes, Grenoble, France; Health Psychology Lab, McGill University, Montréal, France.

Estelle Fall (E)

Université de Lorraine, APEMAC, F-57000, Metz, France.

Julie Bros (J)

Laboratoire Inter-universitaire de Psychologie, Université Grenoble Alpes, Grenoble, France.

Anne-Sophie Le Duc-Banaszuk (AS)

CRCDC-Pays de la Loire, Angers, France.

Morgane Michel (M)

Université Paris Cité, ECEVE, Paris, France; Assistance Publique-Hôpitaux de Paris / Hôpital Robert Debré, Unité d'épidémiologie clinique, Paris, France.

Sébastien Bruel (S)

CIC-Inserm, 1408 CHU de Saint-Etienne, France; Département de Médecine Générale, Faculté de Médecine Jacques Lisfranc, Saint-Etienne-Université Lyon, Saint-Etienne, France.

Laetitia Marie Dit Asse (L)

PRESAGE Institute, Institut de Cancérologie Lucien Neuwirth, Saint-Etienne, France.

Julie Kalecinski (J)

CIC 1408-Vaccinologie, CHU de Saint-Etienne, France.

Stéphanie Bonnay (S)

Université de Lorraine, Inserm, INSPIIRE, F-54000, Nancy, France.

Judith E Mueller (JE)

Institut Pasteur, F-75015 Paris, France; Univ. Rennes, EHESP, CNRS, Inserm, Arènes - UMR 6051, RSMS (Recherche sur les Services et Management en Santé) - U 1309 - F-35000 Rennes, France.

Nathalie Thilly (N)

Université de Lorraine, Inserm, INSPIIRE, F-54000, Nancy, France; Université de Lorraine, CHRU-Nancy, Département Méthodologie, Promotion, Investigation, Nancy, France.

Amandine Gagneux-Brunon (A)

CIC 1408-Vaccinologie, CHU de Saint-Etienne, France; Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Jean Monnet, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530.

Aurélie Gauchet (A)

Laboratoire Inter-universitaire de Psychologie, Université Grenoble Alpes, Grenoble, France. Electronic address: aurelie.gauchet@univ-smb.fr.

Classifications MeSH